Clinical Trials Using Aminocaproic Acid

Clinical trials are research studies that involve people. The clinical trials on this list are studying Aminocaproic Acid. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Aminocaproic Acid versus Platelet Transfusions in Preventing Bleeding in Patients with Thrombocytopenia and Hematologic Malignancies

    This randomized phase II trial studies how well aminocaproic acid works compared with platelet transfusions in preventing bleeding in patients with thrombocytopenia and hematologic malignancies. Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood and may result in easy bruising and excessive bleeding. Aminocaproic acid may increase low blood cell counts caused by hematologic malignancies. It is not yet known whether aminocaproic acid is more effective than platelet transfusion in preventing bleeding in patients with thrombocytopenia and hematologic malignancies.
    Location: 2 locations